Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tecogen (TGEN) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Tecogen (TGEN) over the last 8 years, with Q3 2025 value amounting to -$1713.0.

  • Tecogen's Other Operating Expenses fell 14238.0% to -$1713.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2678.0, marking a year-over-year decrease of 8899.17%. This contributed to the annual value of $12181.0 for FY2024, which is 6635.73% down from last year.
  • According to the latest figures from Q3 2025, Tecogen's Other Operating Expenses is -$1713.0, which was down 14238.0% from $280.0 recorded in Q2 2025.
  • In the past 5 years, Tecogen's Other Operating Expenses ranged from a high of $71375.0 in Q1 2022 and a low of -$29444.0 during Q4 2022
  • In the last 5 years, Tecogen's Other Operating Expenses had a median value of $4111.0 in 2024 and averaged $8258.3.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 38079.34% in 2022, then surged by 69800.0% in 2023.
  • Over the past 5 years, Tecogen's Other Operating Expenses (Quarter) stood at $10486.0 in 2021, then tumbled by 380.79% to -$29444.0 in 2022, then surged by 155.21% to $16257.0 in 2023, then crashed by 74.71% to $4111.0 in 2024, then plummeted by 141.67% to -$1713.0 in 2025.
  • Its Other Operating Expenses was -$1713.0 in Q3 2025, compared to $280.0 in Q2 2025 and $4111.0 in Q4 2024.